1,081
Views
0
CrossRef citations to date
0
Altmetric
Review

Biotinidase Deficiency: Prevalence, Impact And Management Strategies

, & ORCID Icon
Pages 127-133 | Published online: 04 May 2020

References

  • Wolf B, Grier RE, Allen RJ, Goodman SI, Kien CL. Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. Clin Chim Acta. 1983;131(3):273–281. doi:10.1016/0009-8981(83)90096-76883721
  • Moss J, Lane MD.The biotin-dependent enzymes. Adv Enzymol Relat Areas Mol Biol.1971;35:321–442. doi:10.1002/9780470122808.ch74150153
  • Wolf B, Hsia YE, Sweetman L, et al. Multiple carboxylase deficiency: clinical and biochemical improvement following neonatal biotin treatment. Pediatrics. 1981;68(1):113–118.6787561
  • Wolf B, Grier RE, Secor McVoy JR, Heard GS. Biotinidase deficiency: a novel vitamin recycling defect. J Inherit Metab Dis. 1985;8(Suppl 1):53–58. doi:10.1007/BF01800660
  • Wolf B. The neurology of biotinidase deficiency. Mol Genet Metab. 2011;104(1–2):27–34.Review. doi:10.1016/j.ymgme.2011.06.00121696988
  • Wolf B. Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab. 2010;100(1):6–13. doi:10.1016/j.ymgme.2010.01.00320129807
  • Baumgardner MR, Suormala T. Biotin-Responsive Disorders In: Saudubray JM, Baumgardner MR, Walter J, editors. Inborn Metabolic Diseases Diagnosis and Treatment. Heidelberg: Springer-Verlag Berlin Heidelberg; 2016:375–383.
  • Karaca M, Özgül RK, Ö Ü, et al. Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screening. Eur J Pediatr. 2015;174(8):1077–1084. doi:10.1007/s00431-015-2509-525754625
  • Cowan TM, Blitzer MG, Wolf B, Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. Technical standards and guidelines for the diagnosis of biotinidase deficiency. Genet Med. 2010;12(7):464–470. doi:10.1097/GIM.0b013e3181e4cc0f20539236
  • Strovel ET, Cowan TM, Scott AI, Wolf B. Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(10):Oct. doi:10.1038/gim.2017.84
  • Neto EC, Schulte J, Rubim R, et al. Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations. Braz J Med Biol Res. 2004;37(3):295–299. doi:10.1590/S0100-879X200400030000115060693
  • Baykal T, Hüner G, Sarbat G, Demirkol M. Incidence of biotinidase deficiency in Turkish newborns. Acta Paediatr. 1998;87:1102–1103. doi:10.1080/0803525987500315189825985
  • Wolf B, Heard GS, Weissbecker KA, McVoy JR, Grier RE, Leshner RT. Biotinidase deficiency: initial clinical features and rapid diagnosis. Ann Neurol. 1985;18(5):614–617. doi:10.1002/ana.4101805174073853
  • Wolf B. Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have”. Genet Med. 2012;14(6):565–575. doi:10.1038/gim.2011.622241090
  • Mock DM. Skin manifestations of biotin deficiency. Semin Dermatol. 1991;10(4):296–302.1764357
  • Kiykim E, Kiykim A, Cansever MS, Zeybek CA. Biotinidase deficiency mimicking primary immune deficiencies. BMJ Case Rep. 2015;8:2015.
  • Wolf B. Biotinidase Deficiency In: Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews® [Internet]. Seattle: University of Washington; 2000 3 24:1993–2019. Available from http://www.ncbi.nlm.nih.gov/books/NBK1322/. updated 2016 69.
  • Wolf B, Spencer R, Gleason T. Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency. J Pediatr. 2002;140(2):242–246. doi:10.1067/mpd.2002.12193811865279
  • Ferreira P, Chan A, Wolf B. Irreversibility of symptoms with biotin therapy in an adult with profound biotinidase deficiency. JIMD Rep. 2017;36:117–120.28220409
  • Wolf B. Children with profound biotinidase deficiency should be treated with biotin regardless of their residual enzyme activity or genotype. Eur J Pediatr. 2002;161(3):167–168. doi:10.1007/s00431-001-0902-811998918
  • Wolf B, Grier RE, Allen RJ, et al. Phenotypic variation in biotinidase deficiency. J Pediatr. 1983;103(2):233–237. doi:10.1016/S0022-3476(83)80351-56875714
  • Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. J Child Neurol. 2008;23(3):307–314. doi:10.1177/088307380730869818079313
  • Küry S, Ramaekers V, Bézieau S, Wolf B. Clinical utility gene card for: biotinidase deficiency-update 2015. Eur J Hum Genet. 2016;24(7):3–5.
  • Wolf B. Why screen newborns for profound and partial biotinidase deficiency? Mol Genet Metab. 2015;114(3):382–387. doi:10.1016/j.ymgme.2015.01.00325638506
  • Venkataraman V, Balaji P, Panigrahi D, Jamal R. Biotinidase deficiency in childhood. Neurol India. 2013;61(4):411–413. doi:10.4103/0028-3886.11761424005734
  • Canda E, Yazici H, Er E, et al. Single center experience of biotinidase deficiency: 259 patients and six novel mutations. J Pediatr Endocrinol Metab. 2018;31(8):917–926. doi:10.1515/jpem-2018-014829995633
  • Salbert BA, Astruc J, Wolf B. Ophthalmologic findings in biotinidase deficiency. Ophthalmologica. 1993;206(4):177–181. doi:10.1159/0003103878278163
  • Mastrangelo M. Actual insights into treatable inborn errors of metabolism causing epilepsy. J Pediatr Neurosci. 2018;13(1):13–23. doi:10.4103/JPN.JPN_160_1629899766
  • León-Del-Río A. Biotin in metabolism, gene expression, and human disease. J Inherit Metab Dis. 2019;42(4):647–654. doi:10.1002/jimd.1207330746739
  • Hayati AA, Wan-Hitam WH, Cheong MT, Yunus R, Shatriah I. Optic neuritis in a child with biotinidase deficiency: case report and literature review. Clin Ophthalmol. 2012;6:389–395. doi:10.2147/OPTH.S2904822457589
  • Girard B, Bonnemains C, Schmitt E, Raffo E, Bilbault C. Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: a treatable disease. Mult Scler. 2017;23(1):119–122. doi:10.1177/135245851664608727207447
  • Bottin L, Prud’hon S, Guey S, et al. Biotinidase deficiency mimicking neuromyelitis optica: initially exhibiting symptoms in adulthood. Mult Scler. 2015;21(12):1604–1607. doi:10.1177/135245851559645726203071
  • Yilmaz S, Serin M, Canda E, et al. A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency. Metab Brain Dis. 2017;32(3):675–678. doi:10.1007/s11011-017-9984-528281033
  • Wolf B. “Think metabolic” in adults with diagnostic challenges: biotinidase deficiency as a paradigm disorder. Neurol Clin Pract. 2017;7(6):518–522. doi:10.1212/CPJ.000000000000037929431165
  • Swango KL, Demirkol M, Hüner G, et al. Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene. Hum Genet. 1998;102(5):571–575. doi:10.1007/s0043900507429654207
  • Baykal T, Gokcay G, Gokdemir Y, et al. Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases. J Inherit Metab Dis. 2005;28(6):903–912. doi:10.1007/s10545-005-0161-316435182
  • Suormala T, Ramaekers VT, Schweitzer S, et al. Biotinidase Km-variants: detection and detailed biochemical investigations. J Inherit Metab Dis. 1995;18(6):689–700. doi:10.1007/BF024367588750606
  • Ye J, Wang T, Han LS, et al. Diagnosis, treatment, follow-up and gene mutation analysis in four Chinese children with biotinidase deficiency. J Inherit Metab Dis. 2009;32(Suppl1):S295–302. doi:10.1007/s10545-009-1238-119728141
  • Wolf B, Secor McVoy J. A sensitive radioassay for biotinidase activity: deficient activity in tissues of serum biotinidase-deficient individuals. Clin Chim Acta. 1983;135(3):275–281. doi:10.1016/0009-8981(83)90286-36661819
  • Gannavarapu S, Prasad C, DiRaimo J, et al. Biotinidase deficiency: spectrum of molecular, enzymatic and clinical information from newborn screening Ontario, Canada (2007–2014). Mol Genet Metab. 2015;116(3):146–151. doi:10.1016/j.ymgme.2015.08.01026361991
  • Hymes J, Stanley CM, Wolf B. Mutations in BTD causing biotinidase deficiency. Hum Mutat. 2001;18(5):375–381. doi:10.1002/(ISSN)1098-100411668630
  • Schubiger G, Caflisch U, Baumgartner R, Suormala T, Bachmann C. Biotinidase deficiency: clinical course and biochemical findings. J Inherit Metab Dis. 1984;7(3):129–130. doi:10.1007/BF01801771
  • Horvath TD, Matthews NI, Stratton SL, Mock DM, Boysen G. Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin-deficient humans by UPLC-MS/MS. Anal Bioanal Chem. 2011;401(9):2805–2810. doi:10.1007/s00216-011-5356-x21892638
  • Cole H, Reynolds TR, Lockyer JM, et al. Human serum biotinidase. cDNA cloning, sequence, and characterization. J Biol Chem. 1994;269(9):6566–6570.7509806
  • Knight HC, Reynolds TR, Meyers GA, Pomponio RJ, Buck GA, Wolf B. Structure of the human biotinidase gene. Mamm Genome. 1998;9(4):327–330. doi:10.1007/s0033599007609530634
  • Procter M, Wolf B, Mao R. Forty-eight novel mutations causing biotinidase deficiency. Mol Genet Metab. 2016;117(3):369–372. doi:10.1016/j.ymgme.2016.01.00226810761
  • Wolf B. First microdeletion involving only the biotinidase gene that can cause biotinidase deficiency: a lesson for clinical practice. Mol Genet Metab Rep. 2016;2(6):74–76. doi:10.1016/j.ymgmr.2016.02.006
  • Seker Yilmaz B, Mungan NO, Kor D, et al. Twenty-seven mutations with three novel pathologenic variants causing biotinidase deficiency: a report of 203 patients from the southeastern part of Turkey. J Pediatr Endocrinol Metab. 2018;31(3):339–343. doi:10.1515/jpem-2017-040629353266
  • Norrgard KJ, Pomponio RJ, Swango KL, et al. Double mutation (A171T and D444H) is a common cause of profound biotinidase deficiency in children ascertained by newborn screening the the United States. Hum Mutat. 1998;11(5):410. doi:10.1002/(SICI)1098-1004(1998)11:5<410::AID-HUMU10>3.0.CO;2-8
  • Sivri HS, Genç GA, Tokatli A, et al. Hearing loss in biotinidase deficiency: genotype-phenotype correlation. J Pediatr. 2007;150(4):439–442. doi:10.1016/j.jpeds.2007.01.03617382128
  • Desai S, Ganesan K, Hegde A. Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients. Pediatric Radiology 2008;38(8):848–856. doi:10.1007/s00247-008-0904-z
  • Bhat MD, Bindu PS, Christopher R, Prasad C, Verma A. Novel imaging findings in two cases of biotinidase deficiency-a treatable metabolic disorder. Metab Brain Dis. 2015;30(5):1291–1294. doi:10.1007/s11011-015-9690-026037171
  • Raha S, Udani V. Biotinidase deficiency presenting as recurrent myelopathy in a 7-year-old boy and a review of the literature. Pediatr Neurol. 2011;45(4):261–264. doi:10.1016/j.pediatrneurol.2011.06.01021907891
  • Weber P, Scholl S, Baumgartner ER. Outcome in patients with profound biotinidase deficiency: relevance of newborn screening. Dev Med Child Neurol. 2004;46(7):481–484. doi:10.1111/j.1469-8749.2004.tb00509.x15230462
  • Möslinger D, Stöckler-Ipsiroglu S, Scheibenreiter S, et al. Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria. Eur J Pediatr. 2001;160(5):277–282. doi:10.1007/s00431010074011388594
  • Wolf B. High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: implications for individuals with biotin-responsive inherited metabolic disorders. Mol Genet Metab. 2019;127(4):321–324. doi:10.1016/j.ymgme.2019.07.00331320189
  • Luong JHT, Male KB, Glennon JD. Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: an emerging threat. Biotechnol Adv. 2019;37(5):634–641. doi:10.1016/j.biotechadv.2019.03.00730872068
  • Odhaib SA, Mansour AA, Haddad NS. How biotin induces misleading results in thyroid bioassays: case series. Cureus. 2019;11(5):e4727.31363424
  • Wolf B, Heard GS, Jefferson LG, Proud VK, Nance WE, Weissbecker KA. Clinical findings in four children with biotinidase deficiency detected through a statewide neonatal screening program. N Engl J Med. 1985;313(1):16–19. doi:10.1056/NEJM1985070431301044000223
  • Suormala T, Wick H, Baumgartner ER. Low biotinidase activity in plasma of some preterm infants: possible source of false-positive screening results. Eur J Pediatr. 1988;147(5):478–480. doi:10.1007/BF004419703409923
  • Heard GS, Wolf B, Jefferson LG, et al. Neonatal screening for biotinidase deficiency: results of a 1-year pilot study. J Pediatr. 1986;108(1):40–46. doi:10.1016/S0022-3476(86)80766-13944695
  • Wolf B. Biotinidase deficiency should be considered in individuals thought to have multiple sclerosis and related disorders. Mult Scler Relat Disord. 2019;28:26–30. doi:10.1016/j.msard.2018.11.03030551056
  • Jay AM, Conway RL, Feldman GL, Nahhas F, Spencer L, Wolf B. Outcomes of individuals with profound and partial biotinidase deficiency ascertained by newborn screening in Michigan over 25 years. Genet Med. 2015;17(3):205–209. doi:10.1038/gim.2014.10425144890